20350-1-AP

antibody from Proteintech Group

Targeting: SLC1A5 AAAT, ASCT2, M7V1, RDRC

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

20350-1-AP

Provider

Proteintech Group

Product name

ASCT2 antibody

Antibody type

Polyclonal

Description

ASCT2 antibody (Cat. #20350-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, and has been validated for the following applications: IF, IHC, WB,ELISA.

Reactivity

Human, Mouse

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Targeting SERT promotes tryptophan metabolism: mechanisms and implications in colon cancer treatment.

Ye D, Xu H, Xia H, Zhang C, Tang Q, Bi F
Journal of experimental & clinical cancer research : CR 2021 May 18;40(1):173

---

Augmentation of lenvatinib efficacy by topical treatment of miR-634 ointment in anaplastic thyroid cancer.

Kishikawa M, Inoue J, Hamamoto H, Kobayashi K, Asakage T, Inazawa J
Biochemistry and biophysics reports 2021 Jul;26:101009

---

Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.

Hu Y, Tu Z, Lei K, Huang K, Zhu X
Bioscience reports 2021 Dec 22;41(12)

---

The cross-talk between DDR1 and STAT3 promotes the development of hepatocellular carcinoma.

Lin Y, Jin H, Wu X, Jian Z, Zou X, Huang J, Guan R, Wei X
Aging 2020 Jul 27;12(14):14391-14405

---

Improving the Efficacy of EGFR Inhibitors by Topical Treatment of Cutaneous Squamous Cell Carcinoma with miR-634 Ointment.

Inoue J, Fujiwara K, Hamamoto H, Kobayashi K, Inazawa J
Molecular therapy oncolytics 2020 Dec 16;19:294-307